Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus.

Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus.

Item
http://www.wikidata.org/entity/Q37199330
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlled TrialCombined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes.Obesity independently predicts responders to biphasic insulin 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a retrospective cohort studyTreatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analog.Therapeutic Options for the Management of Postprandial Glucose in Patients With Type 2 Diabetes on Basal Insulin.Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)Optimum management of type 2 diabetes--timely introduction, optimization and intensification of basal insulin.Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs.Rapid Acting Insulin Use and Persistence among Elderly Type 2 Diabetes Patients Adding RAI to Oral Antidiabetes Drug Regimens.Comparison of acarbose and voglibose in diabetes patients who are inadequately controlled with basal insulin treatment: randomized, parallel, open-label, active-controlled study.Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated.Intensification of insulin therapy for type 2 diabetic patients in primary care: basal-bolus regimen versus premix insulin analogs: when and for whom?Insulin degludec/liraglutide: innovation-driven combination for advancement in diabetes therapy.Persistence with rapid-acting insulin and its association with A1C level and severe hypoglycemia among elderly patients with type 2 diabetes.Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
P2860

Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus.

Item
http://www.wikidata.org/entity/Q37199330
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Options for the intensificatio ...... h in type 2 diabetes mellitus.
@en
Options for the intensificatio ...... h in type 2 diabetes mellitus.
@nl
type
label
Options for the intensificatio ...... h in type 2 diabetes mellitus.
@en
Options for the intensificatio ...... h in type 2 diabetes mellitus.
@nl
prefLabel
Options for the intensificatio ...... h in type 2 diabetes mellitus.
@en
Options for the intensificatio ...... h in type 2 diabetes mellitus.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P698
P921
P356
P1433
P1476
Options for the intensificatio ...... h in type 2 diabetes mellitus.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1463-1326.2008.00846.X
P478
P577
P698
P921